E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/24/2007 in the Prospect News Special Situations Daily.

Gamco-led investors up stake in PolyMedica to 10.21%

By Lisa Kerner

Charlotte, N.C., Oct. 24 - PolyMedica Corp. investors led by Gamco Asset Management Inc. and Gabelli Funds, LLC purchased 234,412 additional shares of the company's stock between Oct. 15 and Oct. 22 for $52.79 to $52.86 per share.

The investors beneficially own 2,341,226 shares, or 10.21%, of the company, according to a schedule 13D filing with the Securities and Exchange Commission.

On Oct. 9, Gamco and Gabelli reported a 7.52% stake in PolyMedica, up from a 6.34% ownership of the company on Sept. 26.

It was previously reported that PolyMedica agreed on Aug. 28 to be acquired by Medco Health Solutions, Inc. in an all-cash transaction valued at $53.00 per share, or $1.5 billion. Medco is a Franklin Lakes, N.J., pharmacy benefits manager.

PolyMedica provides blood glucose testing supplies and related services to people with diabetes. The company is based in Wakefield, Mass.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.